(Press-News.org) PLYMOUTH MEETING, PA [April 8, 2024] — The National Comprehensive Cancer Network® (NCCN®)—a nonprofit devoted to patient care, research, and education—is announcing the election of Matt Kalaycio, MD, FACP, as Chair of the Board of Directors, with Christopher H. Lieu, MD, elected as Vice-Chair, succeeding Dr. Kalaycio in the position he has held since 2022.
“The exemplary leadership from our board of directors is invaluable as NCCN defines and advances high-quality, high-value, patient-centered cancer care around the world,” said NCCN Chief Executive Officer Crystal S. Denlinger, MD, who took on the role in October of 2023. “Their steady guidance during a transitional time helps us maintain our highly trusted, continuously updated, evidence-based, expert consensus recommendations for cancer care, which were accessed more than 15 million times in 2023 alone. I look forward to working even more closely with Matt and Chris and relying on the substantial expertise, caring, and leadership they bring to these positions.”
Dr. Kalaycio is a leading expert in hematology and medical oncology who specializes in the treatment of leukemia, hematopoietic cell transplantation, and CAR T-Cell therapy. He is Vice-Chair of Cleveland Clinic Cancer Institute and a professor of medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
"NCCN is committed to ensuring that all cancer patients receive the latest evidence-based treatment options by not only informing healthcare providers of available treatments, but also offering education and support to the patients and their caregivers,” said Dr. Kalaycio. “As I take on the role of Chair of the NCCN Board of Directors, I eagerly anticipate further advancing the organization’s mission."
Dr. Lieu is an Associate Professor; Co-Director, Gastrointestinal Medical Oncology; and Associate Director for Clinical Research for the University of Colorado Cancer Center.
He focuses on gastrointestinal cancers, and his research focuses on drug development, including investigating novel strategies for treating and preventing colorectal cancer in young adults. Dr. Lieu is also a member of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Neuroendocrine Tumors and serves on the FDA Oncologic Drugs Advisory Committee.
“I am very honored to serve as the Vice-Chair of the NCCN Board of Directors,” said Dr. Lieu. “The University of Colorado Cancer Center has been an NCCN Member Institution since 2013 and has been heavily involved in NCCN’s mission to improve and facilitate quality, effective, equitable, and accessible cancer care across the globe. I am thrilled to take on this role and am also looking forward to continuing to learn from, and interact with, the incredible leadership at NCCN.”
The position of Board Chair was previously held by John W. Sweetenham, MD, FRCP, FACP, FASCO, Professor of Medicine and Associate Director for Clinical Affairs at the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern in Dallas, Texas.
“We are grateful for everything John has done over the years to improve the lives of people with cancer, both through his work with NCCN and throughout his illustrious career,” said Dr. Denlinger. “He has been a beacon of stable, supportive governance. We will always appreciate the time and thoughtfulness he has shared with us.”
NCCN Board of Directors Treasurer Patrick J. O’Brien, MBA, from Fox Chase Cancer Center, and Secretary Maria M. Gonzalez, MPH, BS, from Stanford Cancer Institute, will continue to serve in their current positions.
# # #
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
END
A new study presented at the European Psychiatric Association Congress 2024 reveals a significant rise in mental health issues among children and adolescents displaced by the war in Ukraine. The research, conducted by the Institute of Forensic Psychiatry of MoH of Ukraine, highlights the devastating impact of prolonged exposure to violence and displacement on the mental well-being of young people.
As per UNICEF’s recent report on “The State of the World’s Children 2021”, the current COVID-pandemic ...
Researchers at McGill University have come up with an innovative approach to improve the energy efficiency of carbon conversion, using waste material from pulp and paper production. The technique they’ve pioneered using the Canadian Light Source at the University of Saskatchewan not only reduces the energy required to convert carbon into useful products, but also reduces overall waste in the environment.
“We are one of the first groups to combine biomass recycling or utilization with CO2 capture,” said Ali ...
Berlin, Germany – 8 April 2024: A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science is presented at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).1
VT is a leading cause of sudden death in patients with heart failure and a reduced ejection fraction.2 Approximately 30% of patients with ischaemic and non-ischaemic cardiomyopathies develop ventricular arrhythmias including VT.3 Typical therapies to prevent VT include antiarrhythmic medication, such as amiodarone, and an implantable ...
Researchers with McMaster University have crafted the first-ever guidelines to help prepare families who plan to build their child’s tolerance to common food allergens.
These international guidelines, published on April 8, 2024 in the Journal of Allergy and Clinical Immunology, standardize the preparation process for families considering oral immunotherapy, a process that involves giving very small amounts of an allergen, like peanuts, to patients and gradually increasing the amount to build up their tolerance.
Until now, ...
Berlin, Germany – 8 April 2024: An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation is published today in EP Europace,1 a journal of the European Society of Cardiology (ESC), and presented at EHRA 2024, a scientific congress of the ESC.2
Lead author Dr. Stylianos Tzeis said: “Ablation is the most effective way to prevent recurrences of atrial fibrillation and delay progression to more advanced forms. Pioneering techniques have emerged since the previous consensus in 2017,3 requiring new advice on who should receive this procedure and how to perform it in the safest and most effective manner.”
Atrial ...
A 10-minute virtual reality (VR) session significantly lessened pain in hospitalized patients with cancer in a recent clinical trial published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. Even a day later, participants experienced sustained benefits.
Most people with cancer experience pain, and treatment usually involves medications including opioids. VR sessions that immerse the user in new environments have been shown to be a noninvasive and nonpharmacologic way to lessen pain in different patient populations, but data are lacking in individuals ...
A new study presented at the European Psychiatric Association Congress 2024 reveals a significant association between prenatal cannabis use disorder (CUD) and an increased risk of neurodevelopmental disorders in offspring, including attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and intellectual disability (ID).
Cannabis remains by far the most consumed illicit drug in Europe. Around 1.3% of adults in the European Union (3.7 million people) are estimated to be ...
A new study presented at the European Psychiatric Association Congress 2024 sheds light on the significant impact of depression on the survival rates and quality of life for women diagnosed with breast cancer. This study, conducted by a team of researchers in Russia, conducted a comprehensive analysis of existing research on the prevalence and impact of depression in breast cancer patients.
Breast cancer is the most common cancer among women and a leading cause of death globally and in the EU, it is estimated that 1 in 11 women in the EU-27 will develop breast cancer ...
Alzheimer's disease and Parkinson's disease, along with stroke, are among the top three neurodegenerative disorders, characterized by the malfunction and progressive degeneration of neurons, the nerve cells. Understanding the mechanisms underlying these neurological disorders and developing therapies requires labeling technologies that can visualize neuronal changes not only in normal conditions but also in disease states.
A research team led by Dr. Kim Yun Kyung from the Brain Science Institute at the Korea Institute of Science and Technology (KIST), in collaboration with Professor Chang Young-Tae's team from Pohang University of Science ...
New research examining the characteristics of physicians with the largest share of patients unvaccinated against SARS-CoV-2 may help increase vaccination rates going forward. The study, published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.230816, found that family physicians in Ontario with the largest percentage of unvaccinated patients generally served patients living in marginalized neighbourhoods and had less support in their practices.
Researchers analyzed linked data on 9060 family physicians with more than 10 million enrolled patients ...
